Key facts
- Evident Vascular’s last known valuation is $94.0M (Mar 2025).
- It has raised $54.0M; the latest was Early Stage VC ($19.0M) in Mar 2025.
- Notable investors include ShangBay Capital, Vensana Capital.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Evident Vascular
- ·The full record, as it builds
Funding rounds
No funding rounds for Evident Vascular are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Evident Vascular
Developer of intravascular ultrasound (IVUS) technology intended to deliver improved image interpretation. The company features advanced AI algorithms that can automatically identify and segment key vascular structures for peripheral vascular image-guided therapy, providing clinicians with real-time insights and guidance to inform decision-making and improve patient care.
- Sector
- Healthcare
- HQ
- San Jose, CA, United States
- Founded
- 2021
- Employees
- 33
- Website
- evidentvascular.com/
- Ownership
- Privately Held (backing)
Evident Vascular doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Evident Vascular shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Evident Vascular in its N-PORT filings yet. We sweep new filings monthly.